BR112017009647A2 - 2-amino-3,5-difluoro-3,6-dimetil-6-fenil-3,4,5,6-tetraidropiridinas como inibidoras da bace1 para tratar a doença de alzheimer - Google Patents
2-amino-3,5-difluoro-3,6-dimetil-6-fenil-3,4,5,6-tetraidropiridinas como inibidoras da bace1 para tratar a doença de alzheimerInfo
- Publication number
- BR112017009647A2 BR112017009647A2 BR112017009647A BR112017009647A BR112017009647A2 BR 112017009647 A2 BR112017009647 A2 BR 112017009647A2 BR 112017009647 A BR112017009647 A BR 112017009647A BR 112017009647 A BR112017009647 A BR 112017009647A BR 112017009647 A2 BR112017009647 A2 BR 112017009647A2
- Authority
- BR
- Brazil
- Prior art keywords
- disease
- tetrahydropyridines
- difluoro
- dimethyl
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
a presente invenção se refere a compostos de acordo com a fórmula (i), compostos esses que são inibidores da enzima bace1. aspectos separados da invenção se referem a composições farmacêuticas compreendendo os referidos compostos e a usos dos compostos no tratamento de transtornos para os quais a redução de depósitos de aß seja benéfica, tal como a doença de alzheimer.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA201400649 | 2014-11-10 | ||
DKPA201500450 | 2015-08-07 | ||
PCT/EP2015/076014 WO2016075062A1 (en) | 2014-11-10 | 2015-11-09 | 2-amino-3,5-difluoro-3,6-dimethyl-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors for treating alzheimer's disease |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112017009647A2 true BR112017009647A2 (pt) | 2017-12-19 |
Family
ID=54476983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112017009647A BR112017009647A2 (pt) | 2014-11-10 | 2015-11-09 | 2-amino-3,5-difluoro-3,6-dimetil-6-fenil-3,4,5,6-tetraidropiridinas como inibidoras da bace1 para tratar a doença de alzheimer |
Country Status (26)
Country | Link |
---|---|
US (1) | US10059669B2 (pt) |
EP (1) | EP3218362B1 (pt) |
JP (1) | JP2017533253A (pt) |
KR (1) | KR20170082529A (pt) |
CN (1) | CN107074809A (pt) |
AU (1) | AU2015345257A1 (pt) |
BR (1) | BR112017009647A2 (pt) |
CA (1) | CA2964305A1 (pt) |
CL (1) | CL2017001113A1 (pt) |
CO (1) | CO2017004530A2 (pt) |
CR (1) | CR20170187A (pt) |
DO (1) | DOP2017000118A (pt) |
EA (1) | EA201790817A1 (pt) |
EC (1) | ECSP17028463A (pt) |
ES (1) | ES2710602T3 (pt) |
IL (1) | IL252091A0 (pt) |
MX (1) | MX2017006048A (pt) |
NI (1) | NI201700056A (pt) |
PE (1) | PE20170947A1 (pt) |
PH (1) | PH12017500829A1 (pt) |
RU (1) | RU2017116197A (pt) |
SG (1) | SG11201703177WA (pt) |
SV (1) | SV2017005434A (pt) |
TN (1) | TN2017000134A1 (pt) |
WO (1) | WO2016075062A1 (pt) |
ZA (1) | ZA201702799B (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA40941A (fr) | 2014-11-10 | 2017-09-19 | H Lundbeck As | 2-amino-5,5-difluoro-6-(fluorométhyl)-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1 |
CR20170187A (es) | 2014-11-10 | 2018-02-01 | H Lundbeck As | 2-Amino-3,5-difluoro-6-metil-6-fenil-3,4,5,6-tetrahidropiridinas en calidad de inhibidores de BACE1 para el tratamiento de la enfermedad de Alzheimer |
JO3458B1 (ar) | 2014-11-10 | 2020-07-05 | H Lundbeck As | 2- أمينو-6- (دايفلوروميثيل) – 5، 5- ديفلورو-6-فينيل-3،4، 5، 6-تيتراهيدروبيريدين كمثبطات bace1 |
JO3627B1 (ar) | 2015-04-30 | 2020-08-27 | H Lundbeck As | إيميدازو بيرازينونات على هيئة مثبطات pde1 |
TW201717948A (zh) | 2015-08-10 | 2017-06-01 | H 朗德貝克公司 | 包括給予2-胺基-3,5,5-三氟-3,4,5,6-四氫吡啶的聯合治療 |
PE20181015A1 (es) | 2015-08-12 | 2018-06-26 | H Lundbeck As | 2-amino-3-fluoro-3-(fluorometil)-6-meti-6-fenil-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 |
US10034861B2 (en) | 2016-07-04 | 2018-07-31 | H. Lundbeck A/S | 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors |
CN106366073B (zh) * | 2016-10-24 | 2018-11-30 | 扬子江药业集团南京海陵药业有限公司 | 一种盐酸替吡嘧啶的制备方法 |
MA46611B1 (fr) | 2016-10-28 | 2020-08-31 | H Lundbeck As | Traitements combinés comprenant des imidazopyrazinones pour le traitement de troubles psychiatriques et/ou cognitifs |
CA3041595A1 (en) | 2016-10-28 | 2018-05-03 | H. Lundbeck A/S | Combination treatments comprising administration of imidazopyrazinones |
BR112018017058A2 (pt) * | 2016-12-21 | 2019-07-02 | H Lundbeck As | 6-amino-5-fluoro-5-(fluorometil)-2,3,4,5-tetra-hidropiridin-2-il-fenil-5-(metóxi-d3)-pirazina-2-carboxamidas e derivados fluorados do mesmo como inibidores de bace1 |
LT3723807T (lt) | 2017-12-14 | 2021-12-10 | H. Lundbeck A/S | Kombinuoti gydymai, apimantys 1h-pirazolo[4,3-b]piridinų vartojimą |
AR113926A1 (es) | 2017-12-14 | 2020-07-01 | H Lundbeck As | Derivados de 1h-pirazolo[4,3-b]piridinas |
CN117447475A (zh) | 2017-12-20 | 2024-01-26 | H.隆德贝克有限公司 | 作为PDE1抑制剂的吡唑并[4,3-b]吡啶和咪唑并[1,5-a]嘧啶 |
CN109970681A (zh) * | 2019-04-19 | 2019-07-05 | 安徽海康药业有限责任公司 | 一种瑞格列奈的合成方法 |
CN113720930A (zh) * | 2021-07-26 | 2021-11-30 | 南京一诺医药科技有限公司 | 一种hplc-ms/ms联用检测人血浆中奥美拉唑的方法 |
CN114235985A (zh) * | 2021-11-25 | 2022-03-25 | 南京海纳医药科技股份有限公司 | 一种hplc-ms/ms联用检测人血浆中胍法辛的方法 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7067507B2 (en) | 2001-06-12 | 2006-06-27 | Pharmacia & Upjohn Company | Macrocycles useful in the treatment of Alzheimer's disease |
GB0124928D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
US7125898B2 (en) | 2002-02-12 | 2006-10-24 | Smithkline Beecham Corporation | Nicotinamide derivatives useful as p38 inhibitors. |
AR077277A1 (es) | 2009-07-09 | 2011-08-17 | Lilly Co Eli | Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer |
ES2607083T3 (es) * | 2010-06-09 | 2017-03-29 | Janssen Pharmaceutica, N.V. | Derivados de 5,6-dihidro-2H-[1,4]oxazin-3-ilamina útiles como inhibidores de beta-secretasa (BACE) |
MX2013008111A (es) | 2011-01-12 | 2013-10-30 | Novartis Ag | Derivados de oxazina y su uso en el tratamiento de transtornos neurologicos. |
JP5715710B2 (ja) | 2011-01-13 | 2015-05-13 | ノバルティス アーゲー | 新規複素環誘導体および神経障害の処置におけるそれらの使用 |
US8754075B2 (en) * | 2011-04-11 | 2014-06-17 | Hoffmann-La Roche Inc. | 1,3-oxazines as BACE1 and/or BACE2 inhibitors |
TW201247635A (en) | 2011-04-26 | 2012-12-01 | Shionogi & Co | Oxazine derivatives and a pharmaceutical composition for inhibiting BAC1 containing them |
EP2718286A1 (en) | 2011-06-07 | 2014-04-16 | F.Hoffmann-La Roche Ag | Halogen-alkyl-1,3 oxazines as bace1 and/or bace2 inhibitors |
UY34278A (es) | 2011-08-25 | 2013-04-05 | Novartis Ag | Derivados novedosos de oxazina y su uso en el tratamiento de enfermedades |
US8338413B1 (en) | 2012-03-07 | 2012-12-25 | Novartis Ag | Oxazine derivatives and their use in the treatment of neurological disorders |
JP2015514073A (ja) | 2012-03-20 | 2015-05-18 | エラン ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニー | スピロ環式ジヒドロ−チアジンおよびジヒドロ−オキサジンbace阻害剤、ならびにその組成物および使用 |
WO2014056816A1 (en) | 2012-10-10 | 2014-04-17 | F. Hoffmann-La Roche Ag | COMBINATION OF AN Aβ ANTIBODY AND A BACE INHIBITOR |
US9540359B2 (en) | 2012-10-24 | 2017-01-10 | Shionogi & Co., Ltd. | Dihydrooxazine or oxazepine derivatives having BACE1 inhibitory activity |
TW201446758A (zh) | 2013-03-01 | 2014-12-16 | Amgen Inc | 作爲β-分泌酶抑制劑的全氟化5,6-二氫-4H-1,3-□-2-胺化合物及其用途 |
TWI639607B (zh) | 2013-06-18 | 2018-11-01 | 美國禮來大藥廠 | Bace抑制劑 |
MX2016010777A (es) | 2014-02-19 | 2016-10-26 | H Lundbeck As | 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer. |
TW201623295A (zh) | 2014-04-11 | 2016-07-01 | 塩野義製藥股份有限公司 | 具有bace1抑制活性之二氫噻及二氫衍生物 |
JO3458B1 (ar) | 2014-11-10 | 2020-07-05 | H Lundbeck As | 2- أمينو-6- (دايفلوروميثيل) – 5، 5- ديفلورو-6-فينيل-3،4، 5، 6-تيتراهيدروبيريدين كمثبطات bace1 |
CR20170187A (es) | 2014-11-10 | 2018-02-01 | H Lundbeck As | 2-Amino-3,5-difluoro-6-metil-6-fenil-3,4,5,6-tetrahidropiridinas en calidad de inhibidores de BACE1 para el tratamiento de la enfermedad de Alzheimer |
MA40941A (fr) | 2014-11-10 | 2017-09-19 | H Lundbeck As | 2-amino-5,5-difluoro-6-(fluorométhyl)-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1 |
TW201717948A (zh) | 2015-08-10 | 2017-06-01 | H 朗德貝克公司 | 包括給予2-胺基-3,5,5-三氟-3,4,5,6-四氫吡啶的聯合治療 |
PE20181015A1 (es) | 2015-08-12 | 2018-06-26 | H Lundbeck As | 2-amino-3-fluoro-3-(fluorometil)-6-meti-6-fenil-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 |
-
2014
- 2014-11-09 CR CR20170187A patent/CR20170187A/es unknown
-
2015
- 2015-11-09 US US15/524,479 patent/US10059669B2/en not_active Expired - Fee Related
- 2015-11-09 AU AU2015345257A patent/AU2015345257A1/en not_active Abandoned
- 2015-11-09 JP JP2017525124A patent/JP2017533253A/ja active Pending
- 2015-11-09 CN CN201580060814.7A patent/CN107074809A/zh active Pending
- 2015-11-09 SG SG11201703177WA patent/SG11201703177WA/en unknown
- 2015-11-09 RU RU2017116197A patent/RU2017116197A/ru unknown
- 2015-11-09 PE PE2017000827A patent/PE20170947A1/es unknown
- 2015-11-09 CA CA2964305A patent/CA2964305A1/en not_active Abandoned
- 2015-11-09 ES ES15790975T patent/ES2710602T3/es active Active
- 2015-11-09 TN TN2017000134A patent/TN2017000134A1/en unknown
- 2015-11-09 EP EP15790975.5A patent/EP3218362B1/en active Active
- 2015-11-09 KR KR1020177012461A patent/KR20170082529A/ko unknown
- 2015-11-09 MX MX2017006048A patent/MX2017006048A/es unknown
- 2015-11-09 BR BR112017009647A patent/BR112017009647A2/pt not_active Application Discontinuation
- 2015-11-09 WO PCT/EP2015/076014 patent/WO2016075062A1/en active Application Filing
- 2015-11-09 EA EA201790817A patent/EA201790817A1/ru unknown
-
2017
- 2017-04-20 ZA ZA2017/02799A patent/ZA201702799B/en unknown
- 2017-05-03 IL IL252091A patent/IL252091A0/en unknown
- 2017-05-04 CL CL2017001113A patent/CL2017001113A1/es unknown
- 2017-05-04 PH PH12017500829A patent/PH12017500829A1/en unknown
- 2017-05-05 CO CONC2017/0004530A patent/CO2017004530A2/es unknown
- 2017-05-09 EC ECIEPI201728463A patent/ECSP17028463A/es unknown
- 2017-05-09 SV SV2017005434A patent/SV2017005434A/es unknown
- 2017-05-09 DO DO2017000118A patent/DOP2017000118A/es unknown
- 2017-05-10 NI NI201700056A patent/NI201700056A/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2016075062A1 (en) | 2016-05-19 |
CN107074809A (zh) | 2017-08-18 |
EA201790817A1 (ru) | 2017-09-29 |
KR20170082529A (ko) | 2017-07-14 |
DOP2017000118A (es) | 2017-07-15 |
US10059669B2 (en) | 2018-08-28 |
PE20170947A1 (es) | 2017-07-13 |
EP3218362B1 (en) | 2019-01-09 |
MX2017006048A (es) | 2017-06-19 |
NI201700056A (es) | 2017-09-22 |
US20170313658A1 (en) | 2017-11-02 |
ZA201702799B (en) | 2018-08-29 |
ECSP17028463A (es) | 2017-08-31 |
EP3218362A1 (en) | 2017-09-20 |
IL252091A0 (en) | 2017-07-31 |
ES2710602T3 (es) | 2019-04-26 |
SV2017005434A (es) | 2017-07-19 |
SG11201703177WA (en) | 2017-05-30 |
TN2017000134A1 (en) | 2018-10-19 |
CR20170187A (es) | 2018-02-01 |
CO2017004530A2 (es) | 2017-07-28 |
CA2964305A1 (en) | 2016-05-19 |
AU2015345257A1 (en) | 2017-05-04 |
CL2017001113A1 (es) | 2017-12-01 |
RU2017116197A (ru) | 2018-12-13 |
PH12017500829A1 (en) | 2017-10-09 |
JP2017533253A (ja) | 2017-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112017009647A2 (pt) | 2-amino-3,5-difluoro-3,6-dimetil-6-fenil-3,4,5,6-tetraidropiridinas como inibidoras da bace1 para tratar a doença de alzheimer | |
ECSP16072941A (es) | 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer | |
BR112017009583A2 (pt) | 2-amino-6-(difluorometil)-5,5-difluoro-6-fenil-3,4,5,6-tetraidropiridinas como inibidoras da bace1 | |
BR112018076534A2 (pt) | compostos heterocíclicos como imunomoduladores | |
BR112017020999A2 (pt) | inibidores de indolamina-2,3-dioxigenase para o tratamento de câncer | |
CO2017005588A2 (es) | 2-amino-5,5-difluoro-6-(fluorometil)-6-fenil-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 | |
BR112015022545A2 (pt) | compostos de pirazolo e os usos disso | |
BR112015021999A2 (pt) | inibidores de indoleamina 2,3-dioxigenase (ido) | |
BR112015005117A2 (pt) | métodos de tratamento da doença de alzheimer e suas composições farmacêuticas | |
BR112014028042A2 (pt) | inibidores de nampt | |
BR112017000584A2 (pt) | inibidores da aldosterona sintase | |
EA201790315A1 (ru) | Модуляторы x-рецепторов печени | |
BR112016020556A8 (pt) | compostos, composição farmacêutica, método de modulação da atividade do receptor de grelina, método para o tratamento de uma doença e usos de um composto | |
BR112016016098A2 (pt) | Compostos orgânicos | |
BR112017005859A2 (pt) | inibidores de aldosterona sintase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |